Point-Of-Care Or Rapid Diagnostics Market

Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care?that is, at the time and place of patient care.

In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.

Point-Of-Care Or Rapid Diagnostics Market contains market size and forecasts of Point-Of-Care Or Rapid Diagnostics in global, including the following market information:

Global Point-Of-Care Or Rapid Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Point-Of-Care Or Rapid Diagnostics Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Point-Of-Care Or Rapid Diagnostics companies in 2021 (%)

The global Point-Of-Care Or Rapid Diagnostics market was valued at 26410 million in 2021 and is projected to reach US$ 48270 million by 2028, at a CAGR of 9.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intensive Care Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Point-Of-Care Or Rapid Diagnostics include Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Thermo Fisher Scientific and Quidel, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Point-Of-Care Or Rapid Diagnostics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Point-Of-Care Or Rapid Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Point-Of-Care Or Rapid Diagnostics Market Segment Percentages, by Type, 2021 (%)

Intensive Care

Covid-19 Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Others

Global Point-Of-Care Or Rapid Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Point-Of-Care Or Rapid Diagnostics Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Independent Laboratories

Others

Global Point-Of-Care Or Rapid Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Point-Of-Care Or Rapid Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Point-Of-Care Or Rapid Diagnostics revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Point-Of-Care Or Rapid Diagnostics revenues share in global market, 2021 (%)

Key companies Point-Of-Care Or Rapid Diagnostics sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Point-Of-Care Or Rapid Diagnostics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Abbott

Danaher

Siemens Healthcare

Bio-Rad Laboratories

BioMerieux

Nova Biomedical

Thermo Fisher Scientific

Quidel

A. Menarini Diagnostics

Becton Dickinson

Biosurfit

Astrego Diagnostics

Werfen

Abionic

Palex Medical/B?lhmann

Horiba Medical

RAL

Vircell

Monlab

Binding Site